The insulin-like growth factors: Potential anabolic agents for the skeleton

Anabolic Treatments for Osteoporosis

Volumn , Issue , 2013, Pages 185-205

  Johansson, Anna ^a   Rosen, Clifford J ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ST JOSEPH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3242732092     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. Rosen, C. J., Donahue, L. R., and Hunter, S. J., IGFs and bone: the osteoporosis connection, Proc. Soc. Exp. Biol. Med., 206, 83, 1994.
2. Blum, W. F., Hall, K., Ranke, M. B., and Wilton, P., Growth hormone insensitivity syndromes: a preliminary report on changes in IGFs and their binding proteins during treatment with recombinant IGF-I, Acta Pediatr. Suppl., 391, 15, 1993.
3. Bautista, C. M., Mohan, S., and Baylink, D. J., IGFs are present in the skeletal tissues of vertebrates, Metabolism, 39, 96, 1990.
4. Mohan, S. and Baylink, D. J., Autocrine and paracrine aspects of bone metabolism, Growth Genet. Hormone, 6, 1, 1990.
5. Canalis, E., Pash, J., and Varghese, S., Skeletal growth factor, Crit. Rev. Eukaryot. Gene Express., 3, 155, 1993.
6. Nicholas, V., Prewett, A., Bettica, P., Mohan, S., Finkleman, R. D., Baylink, D. J., and Farley, J. R., Age-related decreases in IGF-I and transforming growth factors-beta in femoral cortical bone from both men and women: implications for bone loss with aging, J. Clin. Endocrinol. Metab., 78, 1011, 1994.
7. Clemmons, D. R., Hubner, C. C., Jones, J. I., McCusker, R. H., and Busby, W. H., IGFBPs: mechanisms of action at the cellular leve, in Modern Concepts of IGF, Spencer, E. M., Ed., Elsevier, New York, 1991, 475.
8. Clemmons, D. R., Smith-Banks, A., and Underwood, L. E., Reversal of diet induced catabolism by infusion of IGF-I in humans, J. Clin. Endocrinol. Metab., 75, 234, 1992.
9. Rosen, C. J., Donahue, L. R., and Hunter, S. J., Age-related changes in insulin-like growth factor binding proteins, J. Clin. Endocrinol. Metab., 71, 575, 1990.
10. Jones, J. I. and Clemmons, D. R., IGFs and their binding proteins: biological actions.Endocrine Revs., 3, 1995.
11. Bondy, C. A., Clinical Uses of IGF-I, Ann. Intern. Med., 120, 593, 1994.
12. Martin, J. L. and Baxter, R. C., IGFBP-3: Biochemistry and physiology, Growth Regul., 2, 8, 1992.
13. Blum, W. F., Albertsson-Wikkland, K., Rosberg, S., and Ranke, M. B., Serum levels of IGF-I and IGFBP-3 reflect spontaneous GH secretion, J. Clin. Endocrinol. Metab., 76, 1610, 1993.
14. Holly, J. M. and Wass, J. A., IGFs: Autocrine, paracrine or endocrine new perspectives of the somatomedin hypothesis in the light of recent developments, J. Endocrinol., 122, 611, 1989.
15. Binoux, M., Hossenlopp, P., Lassarre, C., and Segovia, B., Degradation of IGFBP-3 by proteases: physiological implications, in Modern Concepts of the IGFs, Spencer, E. M., Ed., Elsevier, New York, 1991, 327.
16. Valentis, B., Bhala, A., and De Angelis, T., The human IGFBP-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene, Mol. Endocrinol., 9, 361, 1995.
17. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seixinger, B. R., and Kley, N., Induction of the growth inhibitor IGFBP-3 by p53, Nature, 377, 646, 1996.
18. Schmid, C., Ernst, M., Zapf, J., and Froesch, E. R., Release of IGFBPs by osteoblasts: stimulation by estradiol and GH, Biochem. Biophys. Res. Commun., 160, 788, 1989.
19. Mohan, S., IGFBPs in bone cell regulation, Growth Regulation, 3, 67, 1993.
20. Scharla, S. H., Strong, D. D., Mohan, S., Baylink, D. J., and Linkhart, T. A., 1,25 dihydroxyvitamin D differentially regulates the production of IGF-I and IGFBP-4 in mouse osteoblasts, Endocrinology, 129, 3139, 1991.
21. Durham, S. K., Riggs, B. L., and Conover, C. A., IGFBP-4 IGFBP-4 protease system in normal human osteoblast-like cells, J. Clin. Endocrinol. Metab., 79, 1752, 1994.
22. Conover, C. A., Bale, L. K., Clarkson, J. T., and Torring, O., Regulation of IGFBP-5 mRNA expression and protein availability in rat osteoblast-like cells, Endocrinology, 132, 2525, 1993.
23. Conover, C. A., Lee, P. D. K., Riggs, B. L., and Powell, D. L., IGFBP-1 expression in human bone cells: regulation by glucocorticoids and insulin, Endocrine Society Meeting, 1996, p. 730.
24. Humbel, R. E., IGF-I and IGF-II, Eur. J. Biochem., 190, 445, 1990.
25. LeRoith, D., Werner, H., Beitner-Johnsson, D., and Roberts, C. T., Molecular and cellular aspects of the IGF-I receptor, Endocrine Revs., 16, 143, 1995.
26. Zapf, J., Schmid, C., and Froesch, E. R., Biological and immunological properties of IGF-I and IGF-II, Clin. Endocrinol. Metab., 13, 3, 1984.
27. Slootweg, M. C., Most, W. W., Van Beek, E., Schot, L. P. C., Papapuculs, S. E., and Löwik, C. W. G. M., Osteoclast formation together with IL-6 production in mouse long bones is increased by IGF-I, J. Endocrinol., 132, 432, 1992.
28. Mochizuki, H., Hakeda, Y., Wakatsuki, N., Usui, N., Akashi, S., Sato, T., Tanaka, K., and Kumegawa, M., IGF-I supports formation and activation of osteoclasts, Endocrinology, 131, 1075, 1991.
29. Canalis, E., Centrella, M., and McCarthy, T. L., Regulation of IGF II production in bone cultures, Endocrinology, 129, 2457, 1991.
30. McCarthy, T. L., Centrella, M., and Canalis, E., Regulatory effects of IGF-I and IGFII on bone collagen synthesis in rat calvarial cultures, Endocrinology, 124, 301, 1989.
31. Canalis, E., Skeletal growth factors, in Osteoporosis, Marcus, R., Feldman, D., and Kelsey, J., Eds., Academic Press, San Diego, 1996, 266.
32. Centrella, M., McCarthy, T. L., and Canalis, E., Receptors for IGF-I and IGF-II in osteoblast-enriched cultures from fetal rat bone, Endocrinology, 126, 39, 1990.
33. Meyers, M. G., Sun, X. J., Cheatham, B., Jachna, B. R., Glasheen, E. M., Backer, J. M., and White, M. F., IRS-1 is a common element in insulin and IGF-I signalling to the phosphatidylinositol 3′ kinase, Endocrinology, 132, 1421, 1993.
34. Rubini, M., Werner, H., Gandini, E., Roberts, C. T., LeRoith, D., and Baserga, R., PDG increases the activity of the promoter of the IGF-I receptor gene, Exp. Cell Res., 211, 374, 1994.
35. Lian, J. B. and Stein, G. S., Osteoblast biology, in Osteoporosis, Marcus, R., Feldman, D., and Kelsey J., Eds., Academic Press, San Diego, 1996, 23.
36. Cohen, P., Graves, H. C., Peehl, D. M., Kamarei, L., Giudice, L. C., and Rosenfeld, R. G., PSA is an IGFBP3 protease found in seminal plasma, J. Clin. Endocrinol. Metab., 75, 1046, 1992.
37. Kanzaki, S., Hilliker, S., Baylink, D. J., and Mohan, S., Evidence that human bone cells in culture produced IGFBP-4 and -5 proteases, Endocrinology, 134, 383, 1994.
38. Canalis, E., Centrella, M., Burch, W., and McCarthy, T. L., IGF-I mediates selective anabolic effects of PTH in bone cultures, J. Clin. Invest., 83, 60, 1989.
39. Holloway, L., Butterfield, G., Hintz, R. L., Gesundheit, N. M., and Marcus, R. M., Effects of human GH on metabolic indices, body composition and bone turnover in healthy elderly women, J. Clin. Endocrinol. Metab., 79, 470, 1994.
40. Dobnig, H. and Turner, R. T., Evidence that intermittent treatment with PTH increases bone formation in adult rats by activation of bone lining cells, Endocrinology, 136, 3632, 1995.
41. Mosekilde, L. and Reeve J., Treatment with PTH peptides, in Osteoporosis, Marcus, J., Feldman, D., and Kelsey, J., Eds., Academic Press, San Diego, 1996, 1293.
42. Watson, P., Lazowski, D., Han, V., Fraher, L. J., Steer, B., and Hodsman, A. B., PTH restores bone mass and enhances osteoblast IGF-I gene expression in ovariectomized rats, Bone, 16, 357, 1995.
43. Schoenle, E., Zapf, J., Humbel, R. E., and Froesch, E. R., IGF-I stimulates growth in hypophysectomized rats, Nature, 296, 252, 1982.
44. Guler, H. P., Zapf, J., Scheweiller, E., and Froeach, E. R., Recombinant IGF-I stimulates growth and has distinct effects on organ size in hypophysectomized rats, Proc. Natl. Acad. Sci. USA, 85, 4889, 1988.
45. Behringer, R. R., Lewin, T. M., Quaife, C. J., Palmitier, R. D., Brinster, R. I., and D’Ercole, A. J., Expression of IGF-I stimulates normal somatic growth in GH deficient mice, Endocrinology, 123, 1033, 1990.
46. Tobias, J. H., Chow, J. W. M., and Chambers, T. J., Opposite effects of IGF-I on the formation of trabecular and cortical bone in adult female rats, Endocrinology, 131, 2387, 1992.
47. Donahue, L. E., Watson, G., and Beamer, W. G., Regulation of metabolic water and protein compartments by IGF-I and, testosterone in GH deficient lit/lit mice, J. Endocrinol., 139, 431, 1993.
48. Rosen, H. N., Chen, V., Cittadini, A., Greenspan, S. L., Douglas, P. S., Moses, A. C., and Beamer, W. G., Treatment with rhGH and IGF-I in rats increases bone mineral content but not bone density, J. Bone Min. Res., 10, 1352, 1995.
49. Verhage, J., Duiker, A. M. H., Visser, W. J., van Herck, E., Van Bree, R., and Bouillon, R., The effects of systemic insulin, IGF-I and GH on bone growth and turnover in spontaneously diabetic BB rats, J. Endocrinol., 134, 173, 1992.
50. Bickle, D. D., Harris, J., Halloran, B. P., and Morey-Holton, E. R., Skeletal unloading induces resistance to IGF-I, J. Bone Min. Res., 9, 1789, 1994.
51. Kalu, D. N., Liu, C. C., Salerno, E., Salih, M., Echon, R., Ray, M., and Hollis, B. W., IGF-I partially prevents ovariectomy-induced bone loss: a comparative study with PTH, J. Bone Min. Res., S1, 548, 1991.
52. Kalu, D. N., Arjmandi, B. H., Liu, C. C., Salih, M. A., and Birnbaum, R. S., Effects of ovariectomy and estrogen on the serum levels of IGF-I and IGFBP-3, Bone Miner., 25, 135, 1994.
53. Ammann, P., Rizzoli, R., Meyer, J. M., Slosman, D., and Bonjour, J. P., IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats, Am. J. Physiol., 265, E770, 1993.
54. Mueller, K., Cortesi, R., Modrowski, D., and Marie, P. J., Stimulation of trabecular bone formation by IGF-I in adult ovariectomized, Am. J. Physiol., 267, E1, 1994.
55. Eberling, P. R., Jones, J. D., O’Fallon, W. M., Janes, C. H., and Riggs, B. L., Short term effects of recombinant hIGF-I on bone turnover in normal women, J. Clin. Endocrinol. Metab., 77, 1384, 1993.
56. Spencer, E. M., Liu, C. C., Si, E. C. C., and Howard, G. A., In vivo actions of IGF-I on bone formation and resorption in rats, Bone, 12, 1991.
57. Bagi, C. M., Brommage, R., Deleon, L., Adams, S., Rosen, D., and Sommer, A., Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats, J. Bone Min. Res., 9, 1301, 1994.
58. Bagi, C., Meulen, M. V., Brommage, R., Rosen, D., and Sommer, A., The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats, Bone, 16, 559, 1995.
59. Bagi, C. M., DeLeon, E., Brommage, R., Rosen, D., and Sommer, A., Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck, Calcif. Tissue Int., 57, 40, 1995.
60. Johannson, A. G. and Rosen, C. J., IGF-I as potential therapy in metabolic bone diseases, in Bone Biology of Bone, Raisz, L. G., Rodan, G., and Bilezikian, J., Eds., Academic Press, San Diego, 1996, chapter 79.
61. Johansson, A. G., Lindh, E., and Ljunghall, S., IGF-I stimulates bone turnover in osteoporosis, Lancet, 339, 1619, 1992.
62. Ebeling, P. R., Jones, J. D., O’Fallon, W. M., Janes, C. H., and Riggs, B. L., Short term effects of recombinant human IGF-I on bone turnover in normal women, J. Clin. Endocrinol. Metab., 77, 1384, 1993.
63. Johansson, A. G., Lindh, E., Kollerup, G., and Ljunghall, S., Dose dependent effects of IGF-I on the metabolism of collagen type I in male osteoporosis, J. Bone Min. Res., 10, S249, 1995.
64. Johansson, A. G., Lindh, E., Blum, W. F., Kollerup, G., Sorensen, O. H., and Ljunghall, S., Effects of growth hormone and IGF-I in men with idiopathic osteoporosis, J. Clin. Endocrinol. Metab., 81, 44, 1996.
65. Grinspoon, S. K., Baum, H. B. A., Peterson, S., and Klibanski, A., Effects of rhIGF-I administration on bone turnover during short-term fasting, J. Clin. Invest., 96, 900, 1995.
66. Ghiron, L. J., Thompson, J. L., Holloway, L., Hintz, R. L., Butterfield, G. E., Hoffman, A. R., and Marcus, R., Effects of recombinant IGF-I and growth hormone on bone turnover in elderly women, J. Bone Min. Res., 10, 1844, 1995.
67. Bianda, T. L., Schmid, C., Hussain, M. A., Keller, A., Glatz, Y., Bouillon, R., and Froesch, E. R., Effects of short term IGF-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and calcitriol production in healthy man, J. Bone Min. Res., 10, S192, 1995.
68. Rubin, C. D., Reed, B., Sakhaee, K., and Pak, C. Y. C., Treating a patient with the Werner syndrome and osteoporosis using recombinant IGF-I, Ann. Intern. Med., 121, 665, 1994.
69. Nesbitt, T. and Drezner, M. K., IGF-I regulation of renal 25 hydroxyvitamin D-1-hydroxylase activity, Endocrinology, 132, 133, 1993.
70. Brixen, K., Nielsen, H. K., Mosekilde, L., and Flyvbjerg, A., A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers, J. Bone Min. Res., 5, 609, 1990.
71. Binnerts, A., Swart, G. R., Wilson, J. H. P., Hoogerbrugge, N., Pols, H. A. P., Birkenhager, J. C., and Lamberts, S. W. J., The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis as well as on body composition, Clin. Endocrinol., 37, 79, 1992.